Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05699642
Other study ID # 2022P000891
Secondary ID
Status Not yet recruiting
Phase Phase 2
First received
Last updated
Start date April 15, 2024
Est. completion date November 30, 2025

Study information

Verified date March 2024
Source Beth Israel Deaconess Medical Center
Contact Daniel Litrownik, BA
Phone 617-754-1423
Email dlitrown@bwh.harvard.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This projects studies the role of tai chi exercise and wearable fitness trackers to promote physical activity in acute coronary syndrome (ACS) survivors.


Description:

This is a two-site randomized controlled trial taking place at Beth Israel Deaconess Medical Center in Boston, MA and The Miriam Hospital in Providence, RI. Seventy (n=70) physically inactive ACS survivors will be randomized to either a 6-month group tai chi program (remotely-delivered classes on Zoom) integrated with a wearable self-monitoring/feedback device plus enhanced usual care (EUC), or to EUC alone. EUC will include usual care provided by participants' providers integrated with printed CHD risk factor education materials. Assessments will be conducted in-person at baseline, 6 months (end of treatment), and 9 months. Our primary outcomes will be focused on study feasibility and acceptability. Secondary outcomes include the following patient-centered outcomes: objectively measured (via accelerometry) moderate-vigorous physical activity, light physical activity, sedentary time, cognitive-behavioral constructs (exercise self-efficacy, intrinsic motivation, depression, stress, HRQL), and cardiometabolic measures (exercise capacity, body weight, lipid profile, blood pressure, fasting plasma glucose).


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 70
Est. completion date November 30, 2025
Est. primary completion date November 30, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. History of ACS (unstable angina, NSTEMI, and STEMI, defined per current AHA/ACC criteria); 2. Age = 18; 3. Being physically inactive (i.e., < 150 min/week of moderate-intensity aerobic PA); 4. Absence of contraindications to physical exercise per the participant's provider evaluation; 5. Access to a digital device with internet connection; 6. Having an active email account and ability to check email at least weekly; 7. Physician clearance to participate in low-moderate intensity exercise (tai chi), including a statement that there is no contraindication to exercise based on post-ACS stress test and other factors, as appropriate; 8. English speaking Exclusion Criteria: 1. Inability or unwillingness to give informed consent; 2. Blood pressure >200/110 or orthostatic systolic blood pressure decrease >20 mmHg at the baseline visit; 3. Uncontrolled/untreated atrial or ventricular arrhythmias or 3rd degree AV block; 4. Within 3 months of a diagnosis of pericarditis or myocarditis; 5. Medical conditions likely to limit lifespan to less than one year; 6. New York Heart Association (NYHA) functional class IV; 7. Severe cognitive impairment (BOMC >10);139 8. Orthopedic problems prohibiting TC practice; 9. Ongoing TC or other mind-body training (i.e., meditation, TC, or yoga) at least weekly; 10. Current enrollment in cardiac rehabilitation; 11. Untreated severe depression (PHQ>=20); 12. Conditions likely to affect study compliance (i.e., moving out of study area, substance use, ongoing untreated psychosis); 13. Symptoms of unstable cardiovascular disease (e.g., shortness of breath or chest pain at rest and/or Canadian Cardiovascular Society Angina Class III-IV)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Tai chi + wearable
The tai chi intervention will be delivered remotely via Zoom Enterprise. Participants will access classes on a phone, tablet, laptop, or desktop computer. Participants will attend 3 classes/week (each lasting 60 min) during weeks 1-12, 2 classes/week during weeks 13-16, and then 1 class every other week during weeks 17-24. Classes include tai chi warm-up exercises, breathing exercises, review and practice of tai chi forms, and cool-down exercises. Participants will be asked to practice tai chi at home 3x per week during the 6 month intervention period using an instructional video provided to them. The Fitbit fitness tracker will be given to each participant along with instructions on how to use the tracker and the Fitbit app on their personal device.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Beth Israel Deaconess Medical Center Lifespan

Outcome

Type Measure Description Time frame Safety issue
Other Socio-demographics Age, sex, race/ethnicity, education, income, insurance status will be collected from the EMR using standard abstraction forms. Baseline
Other Medical history Coronary risk factors; coronary revascularization procedures; ejection fraction; New York Heart Association class; CHD severity (one-, two- or three-vessel from coronary angiogram); co-morbidities; CR information (history of participation, reasons for decline); comorbidities (Charlson index); medications] will be abstracted from medical records using standard abstraction forms that have been validated in previous studies. Baseline
Other Social support Social support will be measured with the Multidimensional Scale of Perceived Social Support is a 12-item, unidimensional tool to measure how one perceives their social support system, including the individual's sources of social support (i.e., family, friends, and significant others). Scores range from 12-84, with a higher score meaning more perceived social support. Baseline
Other Neighborhood barriers to physical activity PANES (Physical Activity Neighborhood Environment Survey) also known as the International Physical Activity Prevalence Study Self-Administered Environmental Module is a 17-item Scale that can be used to assess the environmental factors for walking and bicycling in various neighborhoods. Scores range from 17-68, with higher scores indicating a neighborhood environment that is more conducive to physical activity. Baseline
Primary Recruitment rate Recruitment rate will be evaluated with respect to rate of enrollment, defined as randomization into the trial. Through study completion (an average of 3 years)
Primary Retention rate Retention rate will be quantified by the proportion of subjects who remain in the study to complete our 9-month visit. Through study completion (an average of 3 years)
Primary Intervention enjoyment Intervention enjoyment will be assessed via qualitative interviews 6 months
Primary Intervention adherence Intervention adherence will be measured by collection of class attendance and home practice data. Through study completion (an average of 3 years)
Secondary Physical activity Physical activity will be measured using accelerometers (Actigraph model wGT3X-BT, LLC, Fort Walton Beach, FL). Baseline, 6 and 9 months
Secondary Systolic and diastolic blood pressure Blood pressure will be measured using a Dinamap XL automated BP monitor according to current recommendations. Baseline, 6 and 9 months
Secondary Body weight Body weight will be measured using an electronic scale. Baseline, 6 and 9 months
Secondary Height Height will be measured using a tape measure. Baseline
Secondary Fasting glucose Fasting glucose will be measured after a 12-hour fast according to standardized procedures. All blood samples will be sent to and analyzed at the Lifespan Laboratory located at the Rhode Island Hospital/The Miriam Hospital. Baseline, 6 and 9 months
Secondary Lipid panel Lipid panel will be measured after a 12-hour fast according to standardized procedures. All blood samples will be sent to and analyzed at the Lifespan Laboratory located at the Rhode Island Hospital/The Miriam Hospital. Baseline, 6 and 9 months
Secondary hs-CRP hs-CRP will be measured after a 12-hour fast according to standardized procedures. All blood samples will be sent to and analyzed at the Lifespan Laboratory located at the Rhode Island Hospital/The Miriam Hospital. Baseline, 6 and 9 months
Secondary Quality of life assessed by SF-36 Quality of life will be measured using a short version (8 items) of the Health Survey Short Form (SF-36). Scores range from 0-100, with a higher score indicating a higher quality of life. Baseline, 6 and 9 months
Secondary Intrinsic motivation Intrinsic Motivation Inventory is a 22-item scale validated with four sub-scales: interest/enjoyment, perceived competence, perceived choice, and pressure/tension. A higher score is better, with a scoring range of 22-154. Baseline, 6 and 9 months
Secondary Anxiety, Depression Anxiety, Depression will be assessed using the Hospital Anxiety and Depression Scale, a self-administered questionnaire with two sub-scales (0-21) measuring anxiety and depression, with higher scores indicating greater psychological morbidity. Baseline, 6 and 9 months
Secondary Stress Stress will be measured using the Perceived Stress Scale (PSS) - a 10 items survey with scores ranging from 0 to 40, and higher scores indicating greater stress burden. Baseline, 6 and 9 months
Secondary Mindful awareness Mindful awareness will be assessed using the Five Facets of Mindfulness questionnaire (short form) a 15-item questionnaire that measures the five identified components of mindfulness meditation: observing, acting with awareness, non-judging of inner experience, and non-reactivity to inner experience. Scores ranges from 39-19, with a higher score being better. Baseline, 6 and 9 months
Secondary Exercise self-efficacy Exercise self-efficacy will be measured using the Self-Efficacy for Exercise Scale. This is a 9-item validated scale from McAuley's original barriers scale. Scores range form 9-28, with a higher score meaning more self-efficacy. Baseline, 6 and 9 months
Secondary Exercise capacity Exercise capacity will be assessed via the 6 min walk test (6MWT), a simple, safe and reliable first-line assessment of functional status that correlates with peak oxygen uptake. Baseline, 6 and 9 months
See also
  Status Clinical Trial Phase
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06013813 - Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI N/A
Recruiting NCT05412927 - AngelMed Guardian® System PMA Post Approval Study
Completed NCT02750579 - Early or Delayed Revascularization for Intermediate and High-risk Non ST-elevation Acute Coronary Syndromes? N/A
Completed NCT04102410 - Assessing Force-velocity Profile: an Innovative Approach to Optimize Cardiac Rehabilitation in Coronary Patients N/A
Enrolling by invitation NCT03342131 - Serum Concentration of Wnt2 and Wnt4 in Patients With Acute Coronary Syndrome N/A
Recruiting NCT01218776 - International Survey of Acute Coronary Syndromes in Transitional Countries
Enrolling by invitation NCT04676100 - International CR Registry
Completed NCT03590535 - 5th Generation cTnT in ED ACS
Recruiting NCT05437900 - INSIGHTFUL-FFR Clinical Trial Phase 4
Completed NCT05551429 - Factors Related to Participation in Cardiac Rehabilitation in Patients With Acute Coronary Syndrome
Terminated NCT04316481 - IDE-ALERTS Continued Access Study N/A
Active, not recruiting NCT04475380 - Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
Not yet recruiting NCT04852146 - Electronic Feedback for Data Restitution and Valorization to the Emergency Teams in Aquitaine.
Active, not recruiting NCT02892903 - In the Management of Coronary Artery Disease, Does Routine Pressure Wire Assessment at the Time of Coronary Angiography Affect Management Strategy, Hospital Costs and Outcomes? N/A
Completed NCT02944123 - Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR) Phase 3
Completed NCT04077229 - Piloting Text Messages to Promote Positive Affect and Physical Activity N/A
Not yet recruiting NCT02871622 - BMX Alpha Registry: a Post-market Registry of the BioMatrix Alpha TM N/A
Active, not recruiting NCT02922140 - The Impact of Pharmaceutical Care Practice on Patients in Cardiac Rehabilitation Unit N/A
Completed NCT02673437 - Rivaroxaban ACS Specialist Cohort Event Monitoring Study